A cost of illness study of COVID-19 patients and retrospective modelling of potential cost savings when administering remdesivir during the pandemic “first wave” in a German tertiary care hospital

PURPOSE: First detected in China in 2019, the novel coronavirus disease (COVID-19) has rapidly spread globally. Since then, healthcare systems are exposed to major challenges due to scarce personnel and financial resources. Therefore, this analysis intended to examine treatment costs of COVID-19 inp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeck, Julia, Jakobs, Florian, Kron, Anna, Franz, Jennifer, Cornely, Oliver A., Kron, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371942/
https://www.ncbi.nlm.nih.gov/pubmed/34406606
http://dx.doi.org/10.1007/s15010-021-01685-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371942/
https://www.ncbi.nlm.nih.gov/pubmed/34406606
http://dx.doi.org/10.1007/s15010-021-01685-8

Ejemplares similares